This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsHempshire Group（HMPG）株式概要ヘンプシャー・グループ社は、CBDヘンプスモークの製造・販売を行っている。 詳細HMPG ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6報酬過去 1 年間で収益は42.2%増加しましたリスク分析収益が 100 万ドル未満 ( $197K )マイナスの株主資本 意味のある時価総額がありません ( CA$2M )過去1年間で株主の希薄化は大幅に進んだ +2 さらなるリスクすべてのリスクチェックを見るHMPG Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW487,274 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINROAG487,274 investors already sharing narrativesYour Fair ValueCA$Current PriceCA$0.015226.1% 割高 内在価値ディスカウントEst. Revenue$PastFuture-7m289k2016201920222025202620282031Revenue US$197.5kEarnings US$29.1kAdvancedSet Fair ValueView all narrativesThe Hempshire Group, Inc. 競合他社West Island BrandsSymbol: CNSX:WIBMarket cap: CA$2.0mAion TherapeuticSymbol: CNSX:AIONMarket cap: CA$2.5mCraftport CannabisSymbol: CNSX:CFTMarket cap: CA$2.7mSilo WellnessSymbol: CNSX:SILOMarket cap: CA$1.5m価格と性能株価の高値、安値、推移の概要Hempshire Group過去の株価現在の株価CA$0.01552週高値CA$0.0552週安値CA$0.005ベータ0.131ヶ月の変化0%3ヶ月変化0%1年変化-72.73%3年間の変化n/a5年間の変化n/aIPOからの変化-94.00%最新ニュースお知らせ • Jul 07The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025.お知らせ • Nov 01The Hempshire Group to Transfer Listing from TSX Venture Tier 2 to NEX, Effective November 4, 2024In accordance with TSX Venture Policy 2.5, The Hempshire Group, Inc. has not maintained the requirements for a TSX Venture Tier 2 company. Therefore, effective at the opening on November 4, 2024, the Company's listing will transfer to NEX, the Company's Tier classification will change from Tier 2 to NEX, and the Filing and Service Office will change from Calgary to NEX. As of November 4, 2024, the Company is subject to restrictions on share issuances and certain types of payments as set out in the NEX policies. The trading symbol for the Company will change from HMPG to HMPG.H. There is no change in the Company's name, no change in its CUSIP number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture market. Further to the TSX Venture bulletin dated July 15, 2024, trading in the shares of the Company will remain suspended.New Risk • Jul 07New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 77% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-US$176k). Shareholders have been substantially diluted in the past year (77% increase in shares outstanding). Revenue is less than US$1m (US$197k revenue). Market cap is less than US$10m (CA$2.11m market cap, or US$1.55m). Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end).お知らせ • Jun 27The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024.New Risk • Jun 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.2m free cash flow). Shares are highly illiquid. Negative equity (-US$176k). Revenue is less than US$1m (US$197k revenue). Market cap is less than US$10m (CA$1.22m market cap, or US$888.4k). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Shareholders have been diluted in the past year (2.2% increase in shares outstanding).Board Change • May 08High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Independent Director Samuel Isaac is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.最新情報をもっと見るRecent updatesお知らせ • Jul 07The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025.お知らせ • Nov 01The Hempshire Group to Transfer Listing from TSX Venture Tier 2 to NEX, Effective November 4, 2024In accordance with TSX Venture Policy 2.5, The Hempshire Group, Inc. has not maintained the requirements for a TSX Venture Tier 2 company. Therefore, effective at the opening on November 4, 2024, the Company's listing will transfer to NEX, the Company's Tier classification will change from Tier 2 to NEX, and the Filing and Service Office will change from Calgary to NEX. As of November 4, 2024, the Company is subject to restrictions on share issuances and certain types of payments as set out in the NEX policies. The trading symbol for the Company will change from HMPG to HMPG.H. There is no change in the Company's name, no change in its CUSIP number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture market. Further to the TSX Venture bulletin dated July 15, 2024, trading in the shares of the Company will remain suspended.New Risk • Jul 07New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 77% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-US$176k). Shareholders have been substantially diluted in the past year (77% increase in shares outstanding). Revenue is less than US$1m (US$197k revenue). Market cap is less than US$10m (CA$2.11m market cap, or US$1.55m). Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end).お知らせ • Jun 27The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024.New Risk • Jun 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.2m free cash flow). Shares are highly illiquid. Negative equity (-US$176k). Revenue is less than US$1m (US$197k revenue). Market cap is less than US$10m (CA$1.22m market cap, or US$888.4k). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Shareholders have been diluted in the past year (2.2% increase in shares outstanding).Board Change • May 08High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Independent Director Samuel Isaac is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.お知らせ • Feb 15+ 1 more updateHempshire Group Announces CEO ChangesThe Hempshire Group, Inc. announced that Alex Shegelman, Chief Executive Officer, has advised the Board of Directors that he will retire as Chief Executive Officer effective February 14, 2024, to focus on other commitments. Mr. Shegelman also advised that he will remain on the Board of Directors of the Company. The Board of Directors has appointed Mr. Tom Shuman Chief Executive Officer of Hempshire. Mr. Shuman helped found Hempshire and brings more than 30 years of experience leading CPG sales and marketing teams, both as a founder and executive in various roles. He has extensive experience working across the full sales chain, including with brokers, distributors, wholesalers and retailers, for companies such as Procter & Gamble, Coca-Cola and Dr. Pepper/SevenUp.Reported Earnings • Dec 01Third quarter 2023 earnings released: US$0.006 loss per share (vs US$0.014 loss in 3Q 2022)Third quarter 2023 results: US$0.006 loss per share (improved from US$0.014 loss in 3Q 2022). Revenue: US$49.2k (up 148% from 3Q 2022). Net loss: US$377.4k (loss narrowed 50% from 3Q 2022).Board Change • Nov 16High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Independent Director Samuel Isaac is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.お知らせ • Sep 13The Hempshire Group, Inc. Announces Management Changes, Effective September 29, 2023The Hempshire Group, Inc. announced the resignation of Chief Financial Officer ("CFO") William Hahn, effective September 29, 2023 who has accepted a new position in a different industry. The Company will appoint Paul Stacey to the role of Interim CFO effective September 29, 2023. Mr. Stacey is a seasoned CFO and brings with him extensive and relevant industry experience, and strong executive leadership in the areas of corporate finance, financial planning, strategy and operations. Mr. Stacey served as the Chief Financial Officer of Dr. Murphys – a well-respected cannabis extraction and distribution facility with its own brand in market. Prior to Dr. Murphys, Paul was variably the CFO or the COO of a number of businesses or start-ups through a partnership with private equity funds. As a partner or advisor to private equity firms Paul managed and improved cashflow, grew revenues and optimized assets and pricing for a number of private equity owned consumer packaged goods companies. Earlier in his career, Paul held leadership roles with Gund, Ricoh USA, Cendant and Nabisco. He started his career as an auditor with PriceWaterhouseCoopers.New Risk • Sep 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.2% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$3.3m free cash flow). Share price has been highly volatile over the past 3 months (32% average weekly change). Revenue is less than US$1m (US$168k revenue). Market cap is less than US$10m (CA$4.47m market cap, or US$3.28m). Minor Risk Shareholders have been diluted in the past year (2.2% increase in shares outstanding).Reported Earnings • Sep 03Second quarter 2023 earnings released: US$0.01 loss per share (vs US$0.075 loss in 2Q 2022)Second quarter 2023 results: US$0.01 loss per share (improved from US$0.075 loss in 2Q 2022). Revenue: US$56.2k (up 187% from 2Q 2022). Net loss: US$609.8k (loss narrowed 85% from 2Q 2022).お知らせ • Jul 01The Hempshire Group, Inc. Announces Board ChangesThe Hempshire Group, Inc. (formerly Hoist Capital Corp.) announced that Gail Hannon has advised the Board of Directors that she will resign from her role as a director effective June 30, 2023. The Board of Directors has appointed Jason Warnock as a director of Hempshire effective June 30, 2023. Mr. Warnock is an accomplished global sales leader and executive, bringing more than 20 years of experience driving revenue growth and international market strategy for high-profile, Fortune 500 brands. Mr. Warnock has spent the last 16 years in the cannabis, competitive advertising, communications, and emerging technology fields where his work focused on building companies and brands from the ground up, working on strategic mergers and acquisitions, international cannabis regulations and creating communication and advocacy campaigns. He is experienced in delivering consistent and sustainable business results for numerous consumer packaged goods companies, integrating regulatory and international cannabis supply chains and developing high-performance go-to-market sales teams.お知らせ • Jun 13The Hempshire Group, Inc., Annual General Meeting, Aug 22, 2023The Hempshire Group, Inc., Annual General Meeting, Aug 22, 2023. Agenda: Annual General and Special Meeting.Reported Earnings • Jun 04First quarter 2023 earnings released: US$0.01 loss per share (vs US$0.063 loss in 1Q 2022)First quarter 2023 results: US$0.01 loss per share (improved from US$0.063 loss in 1Q 2022). Revenue: US$65.8k (up 181% from 1Q 2022). Net loss: US$488.1k (loss narrowed 26% from 1Q 2022).Reported Earnings • Dec 01Third quarter 2022 earnings releasedThird quarter 2022 results: US$0.014 loss per share. Net loss: US$756.8k (flat on 3Q 2021).Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CEO, President & Director Marty Marion was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Sep 08The Hempshire Group, Inc. Announces Receipt of Regulatory Approval to Import Its Products into the European UnionThe Hempshire Group, Inc. announced receipt of regulatory approval to import its products into the European Union (EU), and the designation of an exclusive European master distributor. Belgian Approval Hempshire announced it has received notice from the Federal Public Health Food Safety and Environment Service of Belgium, an EU member nation, that MOUNTAIN(R) Smokes have been found to conform with European Union Common Entry Gate (EU-CEG) regulations, including regulations governing tobacco and smokable products and the pertinent regulations setting maximum THC levels at under 0.2%. The notice allows MOUNTAIN(R) Smokes to be legally imported into, and commercially sold in, the country. Access to the European Union (EU) As per EU member state reciprocity for the inter-member commercialization of goods, the Belgian authorization allows Hempshire to pursue commercialization and sales across the EU -- provided it complies with individual member nations' specific 'local' regulations, such as packaging in the local language, and inclusion of any locally-required warning labels.Reported Earnings • Sep 02Second quarter 2022 earnings releasedSecond quarter 2022 results: US$0.075 loss per share. Net loss: US$4.05m (flat on 2Q 2021).Board Change • Aug 26No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CEO, President & Director Martin Marion was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.株主還元HMPGCA PharmaceuticalsCA 市場7D0%-4.5%0.2%1Y-72.7%39.3%28.7%株主還元を見る業界別リターン: HMPG過去 1 年間で39.3 % の収益を上げたCanadian Pharmaceuticals業界を下回りました。リターン対市場: HMPGは、過去 1 年間で28.7 % のリターンを上げたCanadian市場を下回りました。価格変動Is HMPG's price volatile compared to industry and market?HMPG volatilityHMPG Average Weekly Movementn/aPharmaceuticals Industry Average Movement10.3%Market Average Movement9.7%10% most volatile stocks in CA Market16.7%10% least volatile stocks in CA Market3.7%安定した株価: HMPGの株価は、 Canadian市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のHMPGのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイトn/an/aTom Shumanmountainsmokes.comヘンプシャー・グループ社は、CBDヘンプスモークの製造・販売を行っている。マウンテン・スモークのブランド名で有機麻の花、マルチョウ、セージ製品を提供している。本社はカナダのカルガリー。もっと見るThe Hempshire Group, Inc. 基礎のまとめHempshire Group の収益と売上を時価総額と比較するとどうか。HMPG 基礎統計学時価総額CA$2.11m収益（TTM）-CA$3.44m売上高(TTM)CA$271.78k7.8xP/Sレシオ-0.6xPER（株価収益率HMPG は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計HMPG 損益計算書（TTM）収益US$197.49k売上原価US$104.80k売上総利益US$92.69kその他の費用US$2.59m収益-US$2.50m直近の収益報告Sep 30, 2023次回決算日該当なし一株当たり利益（EPS）-0.018グロス・マージン46.94%純利益率-1,265.05%有利子負債／自己資本比率-264.0%HMPG の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/10/12 00:29終値2024/07/15 00:00収益2023/09/30年間収益2022/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋The Hempshire Group, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jul 07The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025.
お知らせ • Nov 01The Hempshire Group to Transfer Listing from TSX Venture Tier 2 to NEX, Effective November 4, 2024In accordance with TSX Venture Policy 2.5, The Hempshire Group, Inc. has not maintained the requirements for a TSX Venture Tier 2 company. Therefore, effective at the opening on November 4, 2024, the Company's listing will transfer to NEX, the Company's Tier classification will change from Tier 2 to NEX, and the Filing and Service Office will change from Calgary to NEX. As of November 4, 2024, the Company is subject to restrictions on share issuances and certain types of payments as set out in the NEX policies. The trading symbol for the Company will change from HMPG to HMPG.H. There is no change in the Company's name, no change in its CUSIP number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture market. Further to the TSX Venture bulletin dated July 15, 2024, trading in the shares of the Company will remain suspended.
New Risk • Jul 07New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 77% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-US$176k). Shareholders have been substantially diluted in the past year (77% increase in shares outstanding). Revenue is less than US$1m (US$197k revenue). Market cap is less than US$10m (CA$2.11m market cap, or US$1.55m). Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end).
お知らせ • Jun 27The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024.
New Risk • Jun 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.2m free cash flow). Shares are highly illiquid. Negative equity (-US$176k). Revenue is less than US$1m (US$197k revenue). Market cap is less than US$10m (CA$1.22m market cap, or US$888.4k). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Shareholders have been diluted in the past year (2.2% increase in shares outstanding).
Board Change • May 08High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Independent Director Samuel Isaac is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Jul 07The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025.
お知らせ • Nov 01The Hempshire Group to Transfer Listing from TSX Venture Tier 2 to NEX, Effective November 4, 2024In accordance with TSX Venture Policy 2.5, The Hempshire Group, Inc. has not maintained the requirements for a TSX Venture Tier 2 company. Therefore, effective at the opening on November 4, 2024, the Company's listing will transfer to NEX, the Company's Tier classification will change from Tier 2 to NEX, and the Filing and Service Office will change from Calgary to NEX. As of November 4, 2024, the Company is subject to restrictions on share issuances and certain types of payments as set out in the NEX policies. The trading symbol for the Company will change from HMPG to HMPG.H. There is no change in the Company's name, no change in its CUSIP number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture market. Further to the TSX Venture bulletin dated July 15, 2024, trading in the shares of the Company will remain suspended.
New Risk • Jul 07New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 77% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-US$176k). Shareholders have been substantially diluted in the past year (77% increase in shares outstanding). Revenue is less than US$1m (US$197k revenue). Market cap is less than US$10m (CA$2.11m market cap, or US$1.55m). Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end).
お知らせ • Jun 27The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024.
New Risk • Jun 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.2m free cash flow). Shares are highly illiquid. Negative equity (-US$176k). Revenue is less than US$1m (US$197k revenue). Market cap is less than US$10m (CA$1.22m market cap, or US$888.4k). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Shareholders have been diluted in the past year (2.2% increase in shares outstanding).
Board Change • May 08High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Independent Director Samuel Isaac is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Feb 15+ 1 more updateHempshire Group Announces CEO ChangesThe Hempshire Group, Inc. announced that Alex Shegelman, Chief Executive Officer, has advised the Board of Directors that he will retire as Chief Executive Officer effective February 14, 2024, to focus on other commitments. Mr. Shegelman also advised that he will remain on the Board of Directors of the Company. The Board of Directors has appointed Mr. Tom Shuman Chief Executive Officer of Hempshire. Mr. Shuman helped found Hempshire and brings more than 30 years of experience leading CPG sales and marketing teams, both as a founder and executive in various roles. He has extensive experience working across the full sales chain, including with brokers, distributors, wholesalers and retailers, for companies such as Procter & Gamble, Coca-Cola and Dr. Pepper/SevenUp.
Reported Earnings • Dec 01Third quarter 2023 earnings released: US$0.006 loss per share (vs US$0.014 loss in 3Q 2022)Third quarter 2023 results: US$0.006 loss per share (improved from US$0.014 loss in 3Q 2022). Revenue: US$49.2k (up 148% from 3Q 2022). Net loss: US$377.4k (loss narrowed 50% from 3Q 2022).
Board Change • Nov 16High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Independent Director Samuel Isaac is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Sep 13The Hempshire Group, Inc. Announces Management Changes, Effective September 29, 2023The Hempshire Group, Inc. announced the resignation of Chief Financial Officer ("CFO") William Hahn, effective September 29, 2023 who has accepted a new position in a different industry. The Company will appoint Paul Stacey to the role of Interim CFO effective September 29, 2023. Mr. Stacey is a seasoned CFO and brings with him extensive and relevant industry experience, and strong executive leadership in the areas of corporate finance, financial planning, strategy and operations. Mr. Stacey served as the Chief Financial Officer of Dr. Murphys – a well-respected cannabis extraction and distribution facility with its own brand in market. Prior to Dr. Murphys, Paul was variably the CFO or the COO of a number of businesses or start-ups through a partnership with private equity funds. As a partner or advisor to private equity firms Paul managed and improved cashflow, grew revenues and optimized assets and pricing for a number of private equity owned consumer packaged goods companies. Earlier in his career, Paul held leadership roles with Gund, Ricoh USA, Cendant and Nabisco. He started his career as an auditor with PriceWaterhouseCoopers.
New Risk • Sep 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.2% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$3.3m free cash flow). Share price has been highly volatile over the past 3 months (32% average weekly change). Revenue is less than US$1m (US$168k revenue). Market cap is less than US$10m (CA$4.47m market cap, or US$3.28m). Minor Risk Shareholders have been diluted in the past year (2.2% increase in shares outstanding).
Reported Earnings • Sep 03Second quarter 2023 earnings released: US$0.01 loss per share (vs US$0.075 loss in 2Q 2022)Second quarter 2023 results: US$0.01 loss per share (improved from US$0.075 loss in 2Q 2022). Revenue: US$56.2k (up 187% from 2Q 2022). Net loss: US$609.8k (loss narrowed 85% from 2Q 2022).
お知らせ • Jul 01The Hempshire Group, Inc. Announces Board ChangesThe Hempshire Group, Inc. (formerly Hoist Capital Corp.) announced that Gail Hannon has advised the Board of Directors that she will resign from her role as a director effective June 30, 2023. The Board of Directors has appointed Jason Warnock as a director of Hempshire effective June 30, 2023. Mr. Warnock is an accomplished global sales leader and executive, bringing more than 20 years of experience driving revenue growth and international market strategy for high-profile, Fortune 500 brands. Mr. Warnock has spent the last 16 years in the cannabis, competitive advertising, communications, and emerging technology fields where his work focused on building companies and brands from the ground up, working on strategic mergers and acquisitions, international cannabis regulations and creating communication and advocacy campaigns. He is experienced in delivering consistent and sustainable business results for numerous consumer packaged goods companies, integrating regulatory and international cannabis supply chains and developing high-performance go-to-market sales teams.
お知らせ • Jun 13The Hempshire Group, Inc., Annual General Meeting, Aug 22, 2023The Hempshire Group, Inc., Annual General Meeting, Aug 22, 2023. Agenda: Annual General and Special Meeting.
Reported Earnings • Jun 04First quarter 2023 earnings released: US$0.01 loss per share (vs US$0.063 loss in 1Q 2022)First quarter 2023 results: US$0.01 loss per share (improved from US$0.063 loss in 1Q 2022). Revenue: US$65.8k (up 181% from 1Q 2022). Net loss: US$488.1k (loss narrowed 26% from 1Q 2022).
Reported Earnings • Dec 01Third quarter 2022 earnings releasedThird quarter 2022 results: US$0.014 loss per share. Net loss: US$756.8k (flat on 3Q 2021).
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CEO, President & Director Marty Marion was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Sep 08The Hempshire Group, Inc. Announces Receipt of Regulatory Approval to Import Its Products into the European UnionThe Hempshire Group, Inc. announced receipt of regulatory approval to import its products into the European Union (EU), and the designation of an exclusive European master distributor. Belgian Approval Hempshire announced it has received notice from the Federal Public Health Food Safety and Environment Service of Belgium, an EU member nation, that MOUNTAIN(R) Smokes have been found to conform with European Union Common Entry Gate (EU-CEG) regulations, including regulations governing tobacco and smokable products and the pertinent regulations setting maximum THC levels at under 0.2%. The notice allows MOUNTAIN(R) Smokes to be legally imported into, and commercially sold in, the country. Access to the European Union (EU) As per EU member state reciprocity for the inter-member commercialization of goods, the Belgian authorization allows Hempshire to pursue commercialization and sales across the EU -- provided it complies with individual member nations' specific 'local' regulations, such as packaging in the local language, and inclusion of any locally-required warning labels.
Reported Earnings • Sep 02Second quarter 2022 earnings releasedSecond quarter 2022 results: US$0.075 loss per share. Net loss: US$4.05m (flat on 2Q 2021).
Board Change • Aug 26No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CEO, President & Director Martin Marion was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
